Benchmark Maintains Speculative Buy on CapsoVision, Lowers Price Target to $10

Benzinga Newsdesk www.benzinga.com Negative 81.9%

Neg 81.9% Neu 0% Pos 0%

Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowers the price target from $14 to $10.